Covid-19: 22 scientific studies show that vaccine mandates are NOT based on science

RIO DE JANEIRO, BRAZIL – The scientific studies compiled below demonstrate that mandates mandating or forcing Covid-19 vaccines provide no overall population health benefit and may even be harmful.

The following research papers and studies raise doubts that Covid-19 vaccine mandates are supported by science and good public health practice.

Anyone, especially politicians, mayors, governors, chancellors, and presidents who are planning to implement Covid passports and/or vaccine mandates should be alerted and those seeking to challenge these mandates are invited to carefully consult these studies.

Read also: Check out our coverage on curated alternative narratives 

Given these scientific study results from around the world, legal action against already introduced vaccine mandates, and in broader terms, Covid passes, have good chances of being won, says a critic attorney association based in Germany. The most effective legal procedures are said to be class actions.

The mandates result in forced separation and segregation from society. They create dangers for people in their professional lives. For example, why would governments impose punitive, career-altering vaccine mandates on an unvaccinated nurse who is probably already immune due to natural exposure?

Mandates also represent a usurpation of freedoms, and a rapidly growing number of critics question the motives behind these mandates when the science shows no public benefit compared to the costs.

Read also: Taiwan suspends Pfizer’s second dose Covid vaccine for adolescents over heart risks

Individuals should decide whether to receive the vaccine based on their own risk assessment in consultation with informed medical professionals.

Marek’s disease model (non-sterilizing, non-neutralizing “leaky” vaccines that reduce symptoms but do not stop infection or transmission) and the concept of original antigenic sin (initial immune system priming impairs the immune response to the pathogen or similar pathogen for life) may explain what the world is potentially facing now with these massive Covid vaccine mandates: immune escape, increased transmission, faster transmission, and potentially “hotter” variants.

Below are studies that question the COVID-19 vaccine mandates:

1. No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups When Infected with SARS-CoV-2 Delta Variant; “Found no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta.”

2. Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant: “No difference in viral loads when comparing unvaccinated individuals to those who have vaccine ‘breakthrough’ infections.”

3. Shedding of InfectiousSARS-CoV-2 Despite Vaccination when the Delta Variant is Prevalent; “Furthermore, individuals with vaccine breakthrough infections frequently test positive with viral loads consistent with the ability to shed infectious viruses”

4. Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections; “Natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity …

5. Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months: A Swedish Total-Population Cohort Study; …while the vaccine provides temporary protection against infection, the efficacy declines below zero and then to negative efficacy territory at approximately 7 months, underscoring that the vaccinated are highly susceptible to infection and eventually become highly infected (more so than the unvaccinated).

6. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar; Qatar study which showed that the vaccine efficacy (Pfizer) declined to near zero by 5 to 6-months and even immediate protection after one to two months were largely exaggerated. –“BNT162b2 -induced protection against infection appears to wane rapidly after its peak right after the second dose.”

7. Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam; Researchers reported “23 complete-genome sequences were obtained. They all belonged to the Delta variant and were phylogenetically distinct from the contemporary Delta variant sequences obtained from community transmission cases, suggestive of ongoing transmission between the workers. — “Viral loads of breakthrough Delta variant infection cases were 251 times higher than those of cases infected with old strains detected between March-April 2020.”

8. Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings; Barnstable, Massachusetts, July 2021 CDC MMWR study found that in 469 cases of COVID-19, there were 74% occurred in fully vaccinated persons.

“The vaccinated had on average more virus in their nose than the unvaccinated who were infected.”

9. An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021; “In conclusion, this outbreak demonstrated that, despite full vaccination and universal masking of HCW, breakthrough infections by the Delta variant via symptomatic and asymptomatic HCW occurred, causing nosocomial infections … — “secondary transmission occurred from those with symptomatic infections despite the use of personal protective equipment (PPE).”

10. Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021; “The PPE and masks were essentially ineffective in the healthcare setting.

“The index cases were usually fully vaccinated and most (if not all transmission) tended to occur between patients and staff who were masked and fully vaccinated, underscoring the high transmission of the Delta variant among vaccinated and masked persons …

11. COVID-19 vaccine surveillance report Week 42, UK Health Security Agency; (see The Rio Times article covering this story)  Information on page 23 raises serious concerns when it reported that “waning of the N antibody response over time and (iii) recent observations from UK Health Security Agency (UKHSA) surveillance data that N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination.”

Also shows a pronounced and very troubling trend, which is that the “double vaccinated persons are showing greater infection (per 100,000) than the unvaccinated, and especially in the older age groups e.g. 30 years and above.”

12. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months; “Six months after receipt of the second dose of the BNT162b2 vaccine, the humoral response was substantially decreased, especially among men, among persons 65 years of age or older, and among persons with immunosuppression.”

13. Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States; “Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States.”

14. Durability of immune responses to the BNT162b2 mRNA vaccine; “Examined the durability of immune responses to the BNT162b2 mRNA vaccine.”

“They ‘analyzed antibody responses to the homologous Wu strain as well as several variants of concern, including the emerging Mu (B.1.621) variant, and T cell responses in a subset of these volunteers at six months (day 210 post-primary vaccination) after the second dose …’ data demonstrate a substantial waning of antibody responses and T cell immunity to SARS-CoV-2 and its variants, at 6 months following the second immunization with the BNT162b2 vaccine.”

15. Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination? Reported that “in the case of the Delta variant, neutralizing antibodies have a decreased affinity for the spike protein, whereas facilitating antibodies display a strikingly increased affinity.

“Thus, ADE may be a concern for people receiving vaccines based on the original Wuhan strain spike sequence (either mRNA or viral vectors).”

16. Hospitalisation among vaccine breakthrough COVID-19 infections; Identified 969 patients who were admitted to a Yale-New Haven Health System hospital with a confirmed positive PCR test for SARS-CoV-2 …

“Observed a higher number of patients with severe or critical illness in those who received the BNT162b2 vaccine than in those who received mRNA-1273 or Ad.26.COV2.S.”

17. The impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission; “Examined the impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission.

They reported that “while vaccination still lowers the risk of infection, similar viral loads in vaccinated and unvaccinated individuals infected with Delta question how much vaccination prevents onward transmission…

“transmission reductions declined over time since second vaccination, for Delta reaching similar levels to unvaccinated individuals by 12 weeks for ChAdOx1 and attenuating substantially for BNT162b2.

“Protection from vaccination in contacts also declined in the 3 months after second vaccination … vaccination reduces transmission of Delta, but by less than the Alpha variant.”

18. SARS-CoV-2 Infection after Vaccination in Health Care Workers in California; “Reported on the resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce.

“Vaccination with mRNA vaccines began in mid-December 2020; by March, 76% of the workforce had been fully vaccinated, and by July, the percentage had risen to 87%. Infections had decreased dramatically by early February 2021…

“coincident with the end of California’s mask mandate on June 15 and the rapid dominance of the B.1.617.2 (delta) variant that first emerged in mid-April and accounted for over 95% of UCSDH isolates by the end of July, infections increased rapidly, including cases among fully vaccinated persons…

“researchers reported that the “dramatic change in vaccine effectiveness from June to July is likely to be due to both the emergence of the delta variant and waning immunity over time.”

19. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study; “Examined the transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community.

“They found that (in 602 community contacts (identified via the UK contract-tracing system) of 471 UK COVID-19 index cases were recruited to the Assessment of Transmission and Contagiousness of COVID-19 in Contacts cohort study and contributed 8145 upper respiratory tract samples from daily sampling for up to 20 days)

“‘vaccination reduces the risk of delta variant infection and accelerates viral clearance. Nonetheless, fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts.”

20. Waning Immunity after the BNT162b2 Vaccine in Israel; “Immunity against the delta variant of SARS-CoV-2 waned in all age groups a few months after receipt of the second dose of vaccine.”

21. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2; The viral load reduction effectiveness declines with time after vaccination, “significantly decreasing at 3 months after vaccination and effectively vanishing after about 6 months.”

22. Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence; “In July, vaccine effectiveness against hospitalization has remained high (mRNA-1273: 81%, 95% CI: 33–96.3%; BNT162b2: 75%, 95% CI: 24–93.9%), but effectiveness against infection was lower for both vaccines (mRNA-1273: 76%, 95% CI: 58–87%; BNT162b2: 42%, 95% CI: 13–62%), with a more pronounced reduction for BNT162b2.”

Join us on Telegram: t.me/theriotimes